ArticleLeukemia2023
Identification of novel genetic loci for risk of multiple myeloma by functional annotation.
Open access · hybridAbstract readLetter
In one paragraph
Article in Leukemia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
- ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance.International journal of cancer · 2026Article
- Genetic architecture of multiple myeloma: From somatic alterations to germline susceptibility and clinical implications.Translational oncology · 2026Review
- Multiple myeloma.Nature reviews. Disease primers · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
66 authors at 20 institutions in 14 countries.
Angelica MacaudaGenomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Klara BriemGenomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Alyssa Clay-GilmourDepartment of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
Wendy CozenDivision of Hematology/Oncology, Division of Hematology/Oncology, Department of Medicine, School of Medicine, Department of Pathology, School of Medicine, Susan and Henry Samueli College of Health Sciences, Chao Family Comprehensive Cancer Center, University of California at Irvine, Irvine, CA, USA.
Asta FörstiDivision of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-9857-4728
Matteo GiaccheriniDepartment of Biology, University of Pisa, Pisa, Italy.
Chiara CorradiDepartment of Biology, University of Pisa, Pisa, Italy.ORCID 0000-0001-6216-9803
Juan SainzGenomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS, Granada, Spain.ORCID 0000-0002-9355-2423
Yasmeen NiaziDivision of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Rob Ter HorstDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0003-0576-5873
Yang LiDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Mihai G NeteaDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0003-2421-6052
Ulla VogelNational Research Centre for the Working Environment, Copenhagen, Denmark.
Kari HemminkiBiomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen, Czech Republic.
Susan L SlagerDivision of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-5173-4712
Judit VarkonyiDepartment of Hematology, Semmelweis University, Budapest, Hungary.
Vibeke AndersenMolecular Diagnostics and Clinical Research Unit, Institute of Regional Health Research, University Hospital of Southern Denmark, Odense, Denmark.ORCID 0000-0002-0127-2863
Elzbieta Iskierka-JazdzewskaDepartment of Hematology, Transplantology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
Joaquin Mártinez-LopezHospital Universitario 12 de Octubre, Instituto de Investigación del Hospital Universitario 12 de Octubre, 28041, Madrid, Spain.ORCID 0000-0001-7908-0063
Jan ZauchaDepartment of Haematology & Transplantology, Medical University of Gdańsk, Gdańsk, Poland.
Nicola J CampDivision of Hematology and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0002-4788-1998
S Vincent RajkumarDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Agnieszka Druzd-SitekDepartment of Lymphoproliferative Diseases, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Parveen BhattiCancer Control Research, BC Cancer, Vancouver, BC, Canada.
Stephen J ChanockDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-2324-3393
Shaji K KumarDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-5392-9284
Edyta SuboczDepartment of Hematology, Warmian-Masurian Cancer Center of The Ministry Of The Interior And Administration's Hospital, Olsztyn, Poland.ORCID 0000-0001-5225-3921
Grzegorz MazurWroclaw Medical University, Wroclaw, Poland.
Stefano LandiDepartment of Biology, University of Pisa, Pisa, Italy.ORCID 0000-0001-8364-6357
Mitchell J MachielaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Andrés JerezHematology and Medical Oncology Department, University Hospital Morales Meseguer, IMIB, Murcia, Spain.
Aaron D NormanDivision of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Michelle A T HildebrandtDepartment of Lymphoma - Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Katalin KadarSt. John's Hospital, Budapest, Hungary.
Sonja I BerndtDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0001-5230-0652
Elad ZivDepartment of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
Gabriele BudaHematology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Arnon NaglerHematology Division Chaim Sheba Medical Center, Tel Hashomer, Israel.
Charles DumontetINSERM 1052/CNRS 5286, CRCL, Lyon, France.
Malgorzata RaźnyDepartment of Hematology, Rydygier Specialistic Hospital, Cracow, Poland.
Marzena WatekDepartment of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.ORCID 0000-0002-3996-200X
Aleksandra ButrymWroclaw Medical University, Wroclaw, Poland.
Norbert GrzaskoDepartment of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
Marek DudzinskiInstitute of Medical Sciences, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland.
Malwina Rybicka-RamosDepartment of Hematology, Specialist Hospital No.1 in Bytom, Academy of Silesia, Faculty of Medicine, Katowice, Poland.
Eva-Laure MateraINSERM 1052/CNRS 5286, CRCL, Lyon, France.
Ramón García-SanzUniversity Hospital of Salamanca, Diagnostic Laboratory Unit in Hematology, University Hospital of Salamanca, IBSAL, CIBERONC, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.ORCID 0000-0003-4120-2787
Hartmut GoldschmidtDepartment of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0003-0961-0035
Krzysztof JamroziakDepartment of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
Artur JurczyszynHematology Department, Jagiellonian University Medical College, Cracow, Poland.ORCID 0000-0001-9796-8365
Esther ClaveroHematology Department, Virgen de las Nieves University Hospital, Granada, Spain.
Graham G GilesCancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.ORCID 0000-0003-4946-9099
Matteo PelosiniU.O. Dipartimento di Ematologia, Azienda USL Toscana Nord Ovest, Livorno, Italy.
Daria ZawirskaDepartment of Hematology, University Hospital, Crakow, Poland.
Marcin KruszewskiDepartment of Hematology, University Hospital No. 2 in Bydgoszcz, Bydgoszcz, Poland.
Herlander MarquesLife and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.
Eva HaastrupDepartment of Clinical Immunology, the Bloodbank, Rigshospitalet, Copenhagen University Hospital, København, Denmark.
José Manuel Sánchez-MaldonadoGenomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS, Granada, Spain.
Uta BertschDepartment of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
Marcin RymkoDepartment of Hematology, Provincial Polyclinical Hospital in Torun, Torun, Poland.
Marc-Steffen RaabDepartment of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
Elizabeth E BrownDepartment of Pathology, School of Medicine at the University of Alabama, Birmingham, AL, USA.
Jonathan N HofmannDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-1043-5812
Celine Vachon *Division of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-1962-9322
Daniele Campa *Department of Biology, University of Pisa, Pisa, Italy.
Federico Canzian *Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. f.canzian@dkfz.de.ORCID 0000-0002-4261-4583
German Cancer Research Center · DEUniversity of Pisa · ITNational Institutes of Health · USHeidelberg University · DEMayo Clinic in Florida · USCentre National de la Recherche Scientifique · FRInstytut Hematologii i Transfuzjologi · PLMayo Clinic in Arizona · USAlliance for Clinical Trials in Oncology · USAustrian Academy of Sciences · ATAzienda Usl Toscana Centro · ITCopenhagen University Hospital · DKFred Hutch Cancer Center · USGdańsk Medical University · PLHospital General Universitario Morales Meseguer · ESHospital Universitario 12 De Octubre · ESHospital Universitario Virgen de las Nieves · ESInstituto de Investigación Biomédica de Salamanca · ESInstituto de Investigación Biosanitaria de Granada · ESJagiellonian University · PL
Funding
Project 4: Targeting Resistance to T-Cell Directed Therapy in Multiple MyelomaP50CA186781 · NCI · MAYO CLINIC ARIZONA · PI Yi Lin · 2015 to 2026
$25.5MImpact of Genetic susceptibility along the continuum from MGUS to MM (Supplement)U01CA271014 · NCI · MAYO CLINIC ROCHESTER · PI Elizabeth E Brown, SHAJI Kunnathu KUMAR · 2022 to 2026
$3.4MEpigenetic contribution to the excess risk of MGUS in African AmericansU01CA249955 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BROWN, ELIZABETH E · 2021 to 2025
$3.0MNCI NIH HHS P50 CA186781NCI NIH HHS U01 CA249955NCI NIH HHS U01 CA271014
Abstract
PubMed holds no abstract for this paper.
Indexed as
Multiple MyelomaGenetic LociGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansPolymorphism, Single Nucleotide
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.